These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 5610818)

  • 1. [Results of clinical testing of a circulatory geriatric agent with vitamins].
    Bense K; Schwarz A
    Landarzt; 1967 Dec; 43(34):1690-1. PubMed ID: 5610818
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of the slightly damaged heart with a cardiotonic agent].
    Guttmann W
    Med Welt; 1969 Sep; 37():2035-7. PubMed ID: 5389269
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experiences with a new vasodilator: 3-(methylhydroxyethylamino)-2-hydroxypropyltheophylline nicotinate].
    Sideri GC; Fumagalli G; Locatelli R
    Arch Patol Clin Med; 1965 Jun; 41(6):479-83. PubMed ID: 5319767
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of xanthinol nicotinate on the small blood vessels.
    Davis E; Rozov H
    Bibl Anat; 1973; 11():334-9. PubMed ID: 4789059
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience with Complamin in peripheral circulation disorders].
    Wittenburg H
    Med Monatsschr; 1969 Dec; 23(12):558-61. PubMed ID: 5387170
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug therapy of arterial circulatory disorders with Lioftal].
    Greif S
    Munch Med Wochenschr; 1969 May; 111(18):1055-8. PubMed ID: 5819199
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of dioxylline phosphate in vascular diseases. Clinical results].
    Rodari T; Tirella G
    Clin Ter; 1972 Jul; 62(1):53-7. PubMed ID: 5071748
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic experiences with an adenosine-theophylline Sodium-nicotinate combination in peripheral circulation disorders].
    Weber G; Vogel A
    Dermatol Wochenschr; 1967 Nov; 153(46):1278-82. PubMed ID: 5588908
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of arterial blood circulatory disorders associated with predominantly autonomic vascular syndrome].
    Lier G
    Munch Med Wochenschr; 1968 Feb; 110(5):292-4. PubMed ID: 5695078
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of nicergoline in peripheral arteriopathies of the lower limbs. Double-blind study].
    Coscia M
    Minerva Cardioangiol; 1972 Sep; 20(9):497-504. PubMed ID: 4561065
    [No Abstract]   [Full Text] [Related]  

  • 11. [The therapy of peripheral circulatory disorders (angiooganopathies) with a blood extract].
    Schirren C; Dietrich K; Biel F
    Hautarzt; 1967 Jun; 18(6):260-4. PubMed ID: 5593511
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of retinal vascular diseases by an arterioleptic. Eucilat (5-benzofuran derivative)].
    Chermezon JP; Cauny M
    Arch Ophtalmol Rev Gen Ophtalmol; 1972 Oct; 32(10):653-60. PubMed ID: 4267678
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the use of an arterial wall extract (Liovasal) in the therapy of some retinal vascular diseases].
    Vitali G; Deledda MG
    Ann Ottalmol Clin Ocul; 1967 Dec; 93(12):1413-29. PubMed ID: 5605996
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience with the vasodilator agent spasmocyclone].
    Priessnitz O
    Med Welt; 1966 Jun; 26():1433-6. PubMed ID: 5962718
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical studies on the effect of hexobendine (Ustimon) on cerebral circulatory disorders].
    Prosenz P; Tschabitscher H
    Wien Klin Wochenschr; 1965 Dec; 77(48):953-5. PubMed ID: 5331101
    [No Abstract]   [Full Text] [Related]  

  • 16. Preliminary results in the treatment of peripheral arteriopathies with a new pharmacologic substance: I-(2"pyrimidyl)4 piperonyl piperazine (ET 495).
    Royer RJ
    Bibl Cardiol; 1969; 26():174-9. PubMed ID: 5402343
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of calcium and vitamin D therapy on arterial and cardiac disease in young adults with childhood-onset end stage renal disease.
    Fournier A; Harbouche L; Mansour J; Shahapuni I
    Nephrol Dial Transplant; 2007 Mar; 22(3):956-7; author reply 957-8. PubMed ID: 17132705
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of circulatory insufficiency with buflomedil chlorhydrate in chronic hemodialysis patients].
    Montemurro NE; Damiano M
    Clin Ter; 1986 Mar; 116(6):485-9. PubMed ID: 3720235
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the therapy of peripheral circulatory disorders with the new angioactivator Tebonin of plant origin].
    Krammer F
    Med Welt; 1966 Jul; 28():1524-8. PubMed ID: 5984513
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of a clinical study on the vasodilator 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
    Lehrach F; Müller R
    Arzneimittelforschung; 1971 Aug; 21(8):1171-4. PubMed ID: 5110012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.